Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Language, Speech and Motor Function in Mild Cognitive Impairment Due to AD and Alzheimer's Disease

NCT06508268 is registered in ClinicalTrials.gov with Hanze University of Applied Sciences Groningen as lead sponsor.

NCT NCT06508268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06508268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Language, Speech and Motor Function in Mild Cognitive Impairment Due to AD and Alzheimer's Disease
Lead sponsor
Hanze University of Applied Sciences Groningen
Phase
Observational
Overall status
Unknown status
Start date
July 12, 2024
Completion date
February 9, 2025
Enrollment
208 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia alzheimers, mci due to ad